|  | Q. | When was MDRNA founded and in what state is it incorporated? | | A. | MDRNA was founded in 1983 and is incorporated in the State of Delaware. |
| Q. | Where is MDRNA located? | | A. | MDRNA's corporate headquarters and R&D operations are located at 3830 Monte Villa MDRNA's corporate headquarters and R&D operations are located at 3830 Monte Villa Parkway, Bothell, Washington 98021. The main telephone number is 425-908-3600 and the main FAX number is 425-908-3650.
Directions to MDRNA. |
| Q. | Where does MDRNA's stock trade? | | A. | The stock trades on on Nasdaq under the symbol MRNA. |
| Q. | How do I purchase stock in MDRNA? | | A. | You need to contact a licensed stockbroker to purchase shares in the company. |
| Q. | Does MDRNA pay dividends? | | A. | The company has not declared or paid any dividends on its capital stock since inception. The company currently anticipates that it will retain all future earnings, if any, for use in the operation and expansion of its business and does not anticipate paying any cash dividends in the foreseeable future. |
| Q. | How do I update my address or transfer my stock? | | A. | To update your address or transfer your shares if you are a registered shareholder of MDRNA common stock, please contact our transfer agent, American Stock Transfer & Trust Company, at 877-777-0800, or visit their website at http://www.amstock.com. If your shares are held in a brokerage account, you must contact your broker to update your address. |
| Q. | What is a transfer agent? | | A. | Transfer agents maintain stock registries for publicly held companies, such as MDRNA. Transfer agents issue and cancel stock certificates, resolve issues regarding lost or stolen certificates, and answer questions from stockholders about their accounts. |
| Q. | What if I hold shares through a broker? | | A. | A transfer agent does not maintain records of shares held through brokerage accounts. Stocks held in a brokerage account are considered to be held in "street name," meaning that those shares are held on behalf of the stockholder by the broker. The brokerage is considered to be the registered shareholder and is responsible with keeping track of the accounts of their clients and providing those clients with information regarding their MDRNA shares, including the delivery of Proxy Statements. |
| Q. | What is MDRNA's fiscal year? When is the next earnings release? | | A. | Our fiscal year ends on December 31. Earnings release dates are listed on the IR Event Calendar . Earnings are typically announced in a press release. A copy of the press release is posted shortly thereafter on our website Press Releases page . To sign up to receive an automatic email of the press release when it is added to the website, visit Email Alerts. |
| Q. | How may I obtain a copy of the company's financial statements, such as an annual report, Form 10-K, or Form 10-Q? | | A. | Annual Reports, Form 10-Ks, Form 10-Qs and other reports are available for viewing on the SEC Filings page. To sign up to receive an automatic electronic link when the Annual Report or latest SEC filing is available, visit Email Alerts. Please help us save paper and mailing charges by viewing such documents online. |
| Q. | Does MDRNA issue quarterly reports? | | A. |
Each quarter the company issues a press release and Form 10-Q, which summarizes its financial performance. SEC filings are available at the SEC Filings page. In addition, the company conducts a conference call to provide investors the opportunity to interact with management. The conference calls are broadcast live on the internet at www.MDRNAinc.com.
|
| Q. | What are the sources of MDRNA's revenues? | | A. | MDRNA may receive revenues from upfront, license fees and milestone payments, and receives revenues from manufacturing of product for a 3rd party and from other sources. |
| Q. | What products are MDRNA currently developing? | | A. | MDRNA is developing an advanced new class of therapeutics utilizing RNA interference (RNAi) technology. For additional information on our product pipeline, go to MDRNA's Pipeline. For additional information on our product pipeline, go to MDRNA's Pipeline. |
| Q. | How can I communicate with members of the board of directors? | | A. | All stockholder communications must (i) be addressed to the Director of Human Resources of the Company at the address of the Company, (ii) be in writing either in print or electronic format, (iii) be signed by the stockholder sending the communication, (iv) indicate whether the communication is intended for the entire Board of Directors, the Nominating Committee, or the independent directors, (v) if the communication relates to a stockholder proposal or director nominee, identify the number of shares held by the stockholder, the length of time such shares have been held, and the stockholder's intention to hold or dispose of such shares, provided that the Board of Directors and the Nominating Committee will not entertain shareholder proposals or shareholder nominations from shareholders who do not meet the eligibility and procedural criteria for submission of shareholder proposals under Commission Rule 14a-8 of Regulation 14A under the Exchange Act and (vi) if the communication relates to a director nominee being recommended by the stockholder, must include appropriate biographical information of the candidate as is required by the Company's Bylaws.
Upon receipt of a stockholder communication that is compliant with the requirements identified above, the Director of Human Resources shall promptly deliver such communication to the appropriate member(s) of the Board of Directors or committee member(s) identified by the stockholder as the intended recipient of such communication by forwarding the communication to either the chairman of the Board of Directors with a copy to the Chief Executive Officer, the chairman of the Nominating Committee, or to each of the independent directors, as the case may be.
The Director of Human Resources may, in his or her sole discretion and acting in good faith, provide copies of any such stockholder communication to any one or more directors and executive officers of the Company, except that in processing any stockholder communication addressed to the independent directors, the Director of Human Resources may not copy any member of management in forwarding such communications. In addition, the Director of Human Resources may, in his or her sole discretion and acting in good faith, not forward certain items if they are deemed of a commercial or frivolous nature or otherwise inappropriate for consideration by the intended recipient, and any such correspondence may be forwarded elsewhere in the Company for review and possible response.
|
|
